REDWOOD CITY, Calif.,
Aug. 2, 2019 /PRNewswire/
-- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty
pharmaceutical company, today announced that it will release second
quarter financial results after market close on Monday, August 5th, 2019. AcelRx management will
host a live webcast and conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on August 5, 2019 to discuss the financial results
and provide an update on the company's business.
The webcast is accessible by visiting the Investors page of the
company's website at www.acelrx.com and clicking on the webcast
link on the Investors home page. The webcast will be accompanied by
a slide presentation. A webcast replay will be available on
the AcelRx website for 90 days following the call by visiting the
Investor page of the company's website at www.acelrx.com.
Investors who wish to participate in the conference call may do
so by dialing (866) 361-2335 for domestic callers, (855) 669-9657
for Canadian callers or (412) 902-4204 for international
callers.
About AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical
company focused on the development and commercialization of
innovative therapies for use in medically supervised settings.
AcelRx's proprietary, non-invasive sublingual formulation
technology delivers sufentanil with consistent pharmacokinetic
profiles. The Company has one approved product in the U.S.,
DSUVIA®(sufentanil sublingual tablet, 30 mcg), known as DZUVEO in
Europe, indicated for the
management of acute pain severe enough to require an opioid
analgesic for adult patients in certified medically supervised
healthcare settings, and one product candidate, Zalviso®(sufentanil
sublingual tablet system, SST system, 15 mcg) being developed as an
innovatively designed patient-controlled analgesia (PCA) system for
reduction of moderate-to-severe acute pain in medically supervised
settings. DZUVEO and Zalviso are both approved products in
Europe. Zalviso is an
investigational drug and not approved in the U.S. For additional
information about AcelRx, please visit www.acelrx.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/acelrx-to-announce-second-quarter-2019-results-and-provide-an-update-on-the-companys-business-on-monday-august-5th-2019-300895694.html
SOURCE AcelRx Pharmaceuticals, Inc.